EPIRUS Biopharmaceuticals, Inc. Insider Trading for March 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in EPIRUS Biopharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in EPIRUS Biopharmaceuticals, Inc. for March 2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 01 2016 | CRXX | EPIRUS Biopharmace ... | Ticktin Robert | General Counsel | Option Exercise | M | 0.00 | 2,134 | 0 | 6,400 | |
| Mar 01 2016 | CRXX | EPIRUS Biopharmace ... | Ticktin Robert | General Counsel | Option Exercise | M | 0.00 | 949 | 0 | 0 | |
| Mar 01 2016 | CRXX | EPIRUS Biopharmace ... | Ticktin Robert | General Counsel | Buy | M | 0.00 | 2,134 | 0 | 6,083 | 3.9 K to 6.1 K (+54.04 %) |
| Mar 01 2016 | CRXX | EPIRUS Biopharmace ... | Ticktin Robert | General Counsel | Buy | M | 0.00 | 949 | 0 | 3,949 | 3 K to 3.9 K (+31.63 %) |
| Mar 01 2016 | CRXX | EPIRUS Biopharmace ... | Shea Thomas A. | Chief Financial Off ... | Option Exercise | M | 0.00 | 3,073 | 0 | 9,217 | |
| Mar 01 2016 | CRXX | EPIRUS Biopharmace ... | Shea Thomas A. | Chief Financial Off ... | Option Exercise | M | 0.00 | 1,044 | 0 | 0 | |
| Mar 01 2016 | CRXX | EPIRUS Biopharmace ... | Shea Thomas A. | Chief Financial Off ... | Payment of Exercise | F | 2.80 | 1,554 | 4,351 | 31,489 | 33 K to 31.5 K (-4.70 %) |
| Mar 01 2016 | CRXX | EPIRUS Biopharmace ... | Shea Thomas A. | Chief Financial Off ... | Buy | M | 0.00 | 3,073 | 0 | 33,043 | 30 K to 33 K (+10.25 %) |
| Mar 01 2016 | CRXX | EPIRUS Biopharmace ... | Shea Thomas A. | Chief Financial Off ... | Buy | M | 0.00 | 1,044 | 0 | 29,970 | 28.9 K to 30 K (+3.61 %) |
| Mar 01 2016 | CRXX | EPIRUS Biopharmace ... | Munshi Amit | Chief Executive Off ... | Option Exercise | M | 0.00 | 9,887 | 0 | 29,661 | |
| Mar 01 2016 | CRXX | EPIRUS Biopharmace ... | Munshi Amit | Chief Executive Off ... | Option Exercise | M | 0.00 | 1,519 | 0 | 0 | |
| Mar 01 2016 | CRXX | EPIRUS Biopharmace ... | Munshi Amit | Chief Executive Off ... | Payment of Exercise | F | 2.80 | 4,305 | 12,054 | 177,083 | 181.4 K to 177.1 K (-2.37 %) |
| Mar 01 2016 | CRXX | EPIRUS Biopharmace ... | Munshi Amit | Chief Executive Off ... | Buy | M | 0.00 | 9,887 | 0 | 181,388 | 171.5 K to 181.4 K (+5.76 %) |
| Mar 01 2016 | CRXX | EPIRUS Biopharmace ... | Munshi Amit | Chief Executive Off ... | Buy | M | 0.00 | 1,519 | 0 | 171,501 | 170 K to 171.5 K (+0.89 %) |
| Mar 01 2016 | CRXX | EPIRUS Biopharmace ... | Wyand Michael | Chief Technical Off ... | Option Exercise | M | 0.00 | 2,608 | 0 | 7,824 | |
| Mar 01 2016 | CRXX | EPIRUS Biopharmace ... | Wyand Michael | Chief Technical Off ... | Option Exercise | M | 0.00 | 1,044 | 0 | 0 | |
| Mar 01 2016 | CRXX | EPIRUS Biopharmace ... | Wyand Michael | Chief Technical Off ... | Payment of Exercise | F | 2.80 | 1,379 | 3,861 | 32,661 | 34 K to 32.7 K (-4.05 %) |
| Mar 01 2016 | CRXX | EPIRUS Biopharmace ... | Wyand Michael | Chief Technical Off ... | Buy | M | 0.00 | 2,608 | 0 | 34,040 | 31.4 K to 34 K (+8.30 %) |
| Mar 01 2016 | CRXX | EPIRUS Biopharmace ... | Wyand Michael | Chief Technical Off ... | Buy | M | 0.00 | 1,044 | 0 | 31,432 | 30.4 K to 31.4 K (+3.44 %) |